Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
2011 ◽
Vol 54
(14)
◽
pp. 4998-5012
◽
2009 ◽
Vol 52
(7)
◽
pp. 2148-2152
◽
2005 ◽
Vol 48
(4)
◽
pp. 1169-1178
◽
2007 ◽
Vol 411
(1)
◽
pp. 22-25
◽
2003 ◽
Vol 279
(3)
◽
pp. 1980-1993
◽
1994 ◽
Vol 32
(2)
◽
pp. 95-100
◽